ABA Life raises MAD 400 million to accelerate its international expansion
ABA Life, the healthcare division of ABA Technology, announces a 400 million dirham investment agreement with Admaius Capital Partners. This strategic transaction aims to accelerate the development of healthcare solutions incorporating artificial intelligence, strengthen the group's industrial capabilities, and support its international expansion from Morocco.
Vision & Positioning
Building a new generation of health technologies from Morocco
The 400 million dirham investment agreement marks a new milestone in the development of ABA Life, the healthcare subsidiary of ABA Technology. Concluded with Admaius Capital Partners, this agreement aims to support the group's growth and strengthen its position in the international HealthTech market.
At the core of this strategy lies the "AI for Sovereign Health" program, dedicated to developing sovereign healthcare technologies based notably on artificial intelligence.
Through this initiative, ABA Life aims to develop an integrated ecosystem in Morocco that combines artificial intelligence, medical devices, telemedicine, connected infrastructure, and healthcare services.
This evolution illustrates an important transformation: technology is no longer limited to supporting medical practices; it contributes to rethinking the infrastructure, tools, and processes that structure healthcare systems.
From this perspective, ABA Technology's vision is part of an approach where artificial intelligence must address concrete needs, support professionals, and help sustainably improve essential services.
Concrete applications & societal impact
From artificial intelligence to integrated medical infrastructures
The announced investment is intended to support three major areas of development:
1. Accelerating innovation in medical artificial intelligence
Through Mediot AI, ABA Life aims to accelerate the design of clinical intelligence solutions intended to support the evolution of medical practices and the operation of healthcare systems.
2. Strengthening industrial and operational capabilities
The mobilized funds are also intended to contribute to the industrialization and large-scale deployment of several activities:
Medical equipment.
Healthcare infrastructure.
Medical devices.
Connected healthcare services.
3. Accelerating international development
The third area concerns the group's international expansion, with the ambition of developing from Morocco technological and medical solutions tailored to the needs of healthcare systems.
This integrated approach opens up prospects for bringing together technological innovation, medical infrastructure, and operational services.
The challenge will be to transform development capabilities into concrete, accessible solutions that can be deployed on a large scale.
Sovereignty & responsibility
Making technological sovereignty a lever for the healthcare of tomorrow
The development of medical technologies designed in Morocco raises a strategic challenge: strengthening local capabilities in a sector essential to societal resilience.
The approach championed by ABA Life through "AI for Sovereign Health" highlights the ambition to develop technological and medical solutions from Morocco, while mastering several stages of their value chain.
This direction is part of a broader reflection on African technological sovereignty, particularly around three dimensions:
Local capabilities: developing skills, technologies, and infrastructure capable of meeting the needs of healthcare systems.
Technological mastery: strengthening national capabilities in the design and industrialization of medical and digital solutions.
Responsibility: ensuring that the integration of artificial intelligence in healthcare complies with security, data protection, and trust requirements.
The agreement with Admaius Capital Partners represents an opportunity to support this ambition and accompany the scaling up of a Moroccan HealthTech player.
For ABA Technology, this momentum reflects a core conviction: digital sovereignty only becomes truly meaningful when it enables the development of useful, responsible solutions tailored to human needs.
Note: the completion of the agreement remains subject to customary closing conditions and authorization from the Competition Council.
